- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacokinetic evaluation of zoledronic acid
Authors
Keywords
-
Journal
Expert Opinion on Drug Metabolism & Toxicology
Volume 7, Issue 7, Pages 911-918
Publisher
Informa Healthcare
Online
2011-05-13
DOI
10.1517/17425255.2011.585156
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epidemiology and risk factors for osteonecrosis of the jaw in cancer patients
- (2010) Ana O. Hoff et al. Annals of the New York Academy of Sciences
- Nitrogen-containing bisphosphonates can inhibit angiogenesis in vivo without the involvement of farnesyl pyrophosphate synthase
- (2010) Verena Stresing et al. BONE
- Preclinical pharmacology of CGP 42′446, a new, potent, heterocyclic bisphosphonate compound
- (2010) Jonathan R. Green et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Zoledronate Stimulates γδ T Cells in Prostate Cancer Patients
- (2010) Michio Naoe et al. ONCOLOGY RESEARCH
- Potential Anticancer Properties of Bisphosphonates
- (2010) Helen L. Neville-Webbe et al. SEMINARS IN ONCOLOGY
- Zoledronic acid induces formation of a pro-apoptotic ATP analogue and isopentenyl pyrophosphate in osteoclasts in vivo and in MCF-7 cells in vitro
- (2009) Johanna Räikkönen et al. BRITISH JOURNAL OF PHARMACOLOGY
- Zoledronic Acid Inhibits Both the Osteolytic and Osteoblastic Components of Osteosarcoma Lesions in a Mouse Model
- (2009) A. Labrinidis et al. CLINICAL CANCER RESEARCH
- Clinical and immunological evaluation of zoledronate-activated Vγ9γδ T-cell-based immunotherapy for patients with multiple myeloma
- (2009) Yu Abe et al. EXPERIMENTAL HEMATOLOGY
- Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer
- (2009) Michael Gnant et al. NEW ENGLAND JOURNAL OF MEDICINE
- Peripheral blood monocytes are responsible for γδ T cell activation induced by zoledronic acid through accumulation of IPP/DMAPP
- (2008) Anke J. Roelofs et al. BRITISH JOURNAL OF HAEMATOLOGY
- Effective inhibition of aromatase inhibitor-associated bone loss by zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole
- (2008) Nigel J. Bundred et al. CANCER
- Differential Effect of Doxorubicin and Zoledronic Acid on Intraosseous versus Extraosseous Breast Tumor Growth In vivo
- (2008) P. D. Ottewell et al. CLINICAL CANCER RESEARCH
- Frequency and Risk Factors Associated With Osteonecrosis of the Jaw in Cancer Patients Treated With Intravenous Bisphosphonates
- (2008) Ana O Hoff et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Farnesyl diphosphate synthase is involved in the resistance to zoledronic acid of osteosarcoma cells
- (2008) B. Ory et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Antitumor Effects of Doxorubicin Followed by Zoledronic Acid in a Mouse Model of Breast Cancer
- (2008) P. D. Ottewell et al. JNCI-Journal of the National Cancer Institute
- Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy
- (2008) Michael Gnant et al. LANCET ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search